Manufacturing

ALLO-329 Shows Rapid Benefits for Systemic Sclerosis, an experimental therapy that utilizes healthy donor cells to create an available, pre-manufactured product designed to address the high cost and logistical hurdles of cell therapy. Systemic sclerosis, a devastating autoimmune condition often

Biological hydrogen generation is often considered economically unfeasible because of the high costs associated with synthetic growth media and feedstocks. Despite this, the global push for a decarbonized energy grid has turned hydrogen into a critical focal point, primarily because its energy

Establishing mathematical models for population growth highlights how plant-based supplements can match the theoretical carrying capacity of full-serum media. As we navigate the bioprocessing landscape of 2026, the reliance on animal-derived components like fetal bovine serum and newborn calf serum

Practical experiments in ethics-integrated education are essential for developing a workforce capable of navigating the moral complexities of modern genetic engineering. As synthetic biology moves from the theoretical confines of academic research into the rapid-fire pace of industrial

The biological hurdles of treating solid tumors with T-cell therapy are being decoded through new findings linking tumor lesion diameters to the ultimate durability of the patient response. At the current Society for Immunotherapy of Cancer Annual Meeting, researchers presented updated data

The complexity of molecular transformations in pharmaceutical synthesis demands enzymes that maintain high selectivity without sacrificing the speed of the chemical reaction. These biological catalysts are the foundation of many life-sustaining processes, yet their natural forms are rarely suited